Journal of Clinical Microbiology, January 1999, p. 56-62, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The International Escherichia and Klebsiella
Reference Centre (WHO), Statens Serum Institut, and Department of
Clinical Microbiology, Hvidovre Hospital, Copenhagen,
Denmark,1 and
Área de
Microbiología,
Received 15 June 1998/Returned for modification 24 August
1998/Accepted 19 October 1998
We have previously described an inhibition enzyme-linked
immunosorbent assay method for the O typing of O1 lipopolysaccharide from Klebsiella pneumoniae which overcomes the technical
problems and limitations of the classical O-typing method. In this
study, we have extended the method to all of the currently recognized O
types. The method was validated by studying the prototype strains that
have defined the O groups by the classical tube
agglutinatination O-typing method. Based on these results, we confirmed
the O types of 60 of 64 typeable strains, and we propose a revised
O-antigenic scheme, with minor but necessary changes, consisting of
serogroups or serotypes O1, O2, O2ac, O3, O4, O5, O7, O8, and O12.
Application of this typing method to 638 K. pneumoniae
clinical isolates from Denmark, Spain, and the United States from
different sources (blood, urine, and others) showed that up to 80% of
these isolates belong to serotypes or serogroups O1, O2, O3, and O5,
independently of the source of isolation, and that a major group of
nontypeable isolates, representing about 17% of the total, consists of
half O+ and half O
strains. Differences were
observed, however, in the prevalence of the lipopolysaccharide O types
or groups, depending on the country and isolation source.
*
Corresponding author. Mailing address: Carretera de
Valldemosa Km. 7,5, 07071-Palma de Mallorca, Spain. Phone:
34-971-173.335. Fax: 34-971-173.184. E-mail:
dbsjbb0{at}ps.uib.es.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|